“5-Azacytidine Treatment Inhibits the Development of Lung Cancer Models via Epigenetic Reprogramming and Activation of Cellular Pathways With Anti-Tumor Activity”. Medicine and Pharmacy Reports 97, no. 4 (September 23, 2024): 488–506. Accessed November 14, 2026. https://medpharmareports.com/index.php/mpr/article/view/2777.